Search
for
Sort by
Research 30 of 380
- Neuroactive Steroid Levels are Modified in Cerebrospinal Fluid and Plasma of Post‐Finasteride Patients Showing Persistent Sexual Side Effects and Anxious/Depressive Symptomatology
- Patients treated for male pattern hair with finasteride show, after discontinuation of the drug, altered levels of neuroactive steroids in cerebrospinal fluid and plasma
- Prevalence, Symptomatology and Herbal Management of Polycystic Ovarian Syndrome
- Abstracts from the 17th Congress of the European Society for Dermatology and Psychiatry
- Post-finasteride syndrome: An emerging clinical problem
- Síndrome postfinasterida y disfunción eréctil. Caso clínico y revisión de la literatura
- Anxiety, Depression, and Quality of Life in Women with Polycystic Ovarian Syndrome
- Index of Suspicion
- Association of Suicidality and Depression With 5α-Reductase Inhibitors
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction
- Persistent Erectile Dysfunction after Discontinuation of 5-Alpha Reductase Inhibitor Therapy in Rats Depending on the Duration of Treatment
- Isoallopregnanolone reduces tic‐like behaviours in the D1 CT ‐7 mouse model of Tourette syndrome
- Finasteride and androgenic alopecia; from therapeutic options to medical implications
- Nocebo effect in Dermatology
- Impact of Alpha Blockers, 5-alpha Reductase Inhibitors and Combination Therapy on Sexual Function
- Association Between 5-Alpha Reductase Inhibitor Use and The Risk of Depression: A Meta-Analysis.
- Can gut flora changes be new biomarkers for depression?
- The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Advances in Knowledge of Androgens: How Intentional and Accidental Neurosteroid Changes Inform Us of Their Action and Role
- The potential involvement of cholinergic system in finasteride induced cognitive dysfunction
- The nocebo effect: A clinicians guide
- Stress and Psychoneuroimmunologic Factors in Dermatology
- Coping in Women With Polycystic Ovary Syndrome: Implications for Practitioners
- Temperament and character differences of patients with polycystic ovary syndrome
- Cognitive, emotional, physical, and behavioral stress-related symptoms and coping strategies among university students during the third wave of COVID-19 pandemic
- Three-Dimensional Proteome-Wide Scale Screening for the 5-Alpha Reductase Inhibitor Finasteride: Identification of a Novel Off-Target